aluates Reports

$ 0.0

Global Precision Cancer Medicine Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-35A15351

Global Precision Cancer Medicine Market Research Report 2023

BUY CHAPTERS

Global Precision Cancer Medicine Market Research Report 2024

Code: QYRE-Auto-35A15351

Report

August 2024

Pages:103

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Precision Cancer Medicine Market Size

The global Precision Cancer Medicine market was valued at US$ 161690 million in 2023 and is anticipated to reach US$ 350430 million by 2030, witnessing a CAGR of 12.5% during the forecast period 2024-2030.

Precision Cancer Medicine Market

Precision cancer medicines, are medications designed to specifically target the unique genetic or molecular characteristics of an individual patient's cancer. These drugs are a central component of personalized cancer medicine and are chosen based on the genomic and molecular profiling of the patient's tumor.

Precision cancer medicine, also known as personalized or targeted cancer therapy, is driven by the growing understanding of cancer's molecular and genetic complexity. Advances in genomics and biomarker identification have enabled the development of therapies tailored to an individual's specific cancer characteristics. This approach offers the potential for more effective treatments with fewer side effects compared to traditional chemotherapy. The market benefits from increasing research in oncology, the rise of precision diagnostics, and the growing availability of targeted therapies. However, challenges include the high cost of genetic testing and targeted treatments, as well as the need for comprehensive molecular profiling. Additionally, regulatory approvals and insurance coverage for these therapies can be complex. To maximize the potential of precision cancer medicine, stakeholders must address these challenges, improve accessibility, and continue research into novel biomarkers and therapies to provide tailored cancer care for patients.

This report aims to provide a comprehensive presentation of the global market for Precision Cancer Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Precision Cancer Medicine.

Report Scope

The Precision Cancer Medicine market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Precision Cancer Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Precision Cancer Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Precision Cancer Medicine Market Report

Report Metric	Details
Report Name	Precision Cancer Medicine Market
Accounted market size in 2023	US$ 161690 million
Forecasted market size in 2030	US$ 350430 million
CAGR	12.5%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Cancer Immunotherapy Targeted Therapy
Segment by Application	Lung Cancer Breast Cancer Prostate Cancer Blood-related Cancer Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, GSK, Exelixis, Regeneron, Innovent, Hengrui Medicine
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Precision Cancer Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Precision Cancer Medicine Market growing?

Ans: The Precision Cancer Medicine Market witnessing a CAGR of 12.5% during the forecast period 2024-2030.

What is the Precision Cancer Medicine Market size in 2030?

Ans: The Precision Cancer Medicine Market size in 2030 will be US$ 350430 million.

Who are the main players in the Precision Cancer Medicine Market report?

Ans: The main players in the Precision Cancer Medicine Market are AbbVie, Johnson & Johnson, Novartis, Gilead Sciences, Roche, Bristol-Myers Squibb, Amgen, AstraZeneca, Merck & Co, Takeda, Merck KGaA, Seagen, Eli Lilly, Ono Pharmaceutical, Pfizer, GSK, Exelixis, Regeneron, Innovent, Hengrui Medicine

What are the Application segmentation covered in the Precision Cancer Medicine Market report?

Ans: The Applications covered in the Precision Cancer Medicine Market report are Lung Cancer, Breast Cancer, Prostate Cancer, Blood-related Cancer, Other

What are the Type segmentation covered in the Precision Cancer Medicine Market report?

Ans: The Types covered in the Precision Cancer Medicine Market report are Cancer Immunotherapy, Targeted Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Precision Cancer Medicine Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Cancer Immunotherapy

1.2.3 Targeted Therapy

1.3 Market by Application

1.3.1 Global Precision Cancer Medicine Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Lung Cancer

1.3.3 Breast Cancer

1.3.4 Prostate Cancer

1.3.5 Blood-related Cancer

1.3.6 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Precision Cancer Medicine Market Perspective (2019-2030)

2.2 Precision Cancer Medicine Growth Trends by Region

2.2.1 Global Precision Cancer Medicine Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Precision Cancer Medicine Historic Market Size by Region (2019-2024)

2.2.3 Precision Cancer Medicine Forecasted Market Size by Region (2025-2030)

2.3 Precision Cancer Medicine Market Dynamics

2.3.1 Precision Cancer Medicine Industry Trends

2.3.2 Precision Cancer Medicine Market Drivers

2.3.3 Precision Cancer Medicine Market Challenges

2.3.4 Precision Cancer Medicine Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Precision Cancer Medicine Players by Revenue

3.1.1 Global Top Precision Cancer Medicine Players by Revenue (2019-2024)

3.1.2 Global Precision Cancer Medicine Revenue Market Share by Players (2019-2024)

3.2 Global Precision Cancer Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Precision Cancer Medicine Revenue

3.4 Global Precision Cancer Medicine Market Concentration Ratio

3.4.1 Global Precision Cancer Medicine Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Medicine Revenue in 2023

3.5 Precision Cancer Medicine Key Players Head office and Area Served

3.6 Key Players Precision Cancer Medicine Product Solution and Service

3.7 Date of Enter into Precision Cancer Medicine Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Precision Cancer Medicine Breakdown Data by Type

4.1 Global Precision Cancer Medicine Historic Market Size by Type (2019-2024)

4.2 Global Precision Cancer Medicine Forecasted Market Size by Type (2025-2030)

5 Precision Cancer Medicine Breakdown Data by Application

5.1 Global Precision Cancer Medicine Historic Market Size by Application (2019-2024)

5.2 Global Precision Cancer Medicine Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Precision Cancer Medicine Market Size (2019-2030)

6.2 North America Precision Cancer Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Precision Cancer Medicine Market Size by Country (2019-2024)

6.4 North America Precision Cancer Medicine Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Precision Cancer Medicine Market Size (2019-2030)

7.2 Europe Precision Cancer Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Precision Cancer Medicine Market Size by Country (2019-2024)

7.4 Europe Precision Cancer Medicine Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Precision Cancer Medicine Market Size (2019-2030)

8.2 Asia-Pacific Precision Cancer Medicine Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Precision Cancer Medicine Market Size by Region (2019-2024)

8.4 Asia-Pacific Precision Cancer Medicine Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Precision Cancer Medicine Market Size (2019-2030)

9.2 Latin America Precision Cancer Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Precision Cancer Medicine Market Size by Country (2019-2024)

9.4 Latin America Precision Cancer Medicine Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Precision Cancer Medicine Market Size (2019-2030)

10.2 Middle East & Africa Precision Cancer Medicine Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Precision Cancer Medicine Market Size by Country (2019-2024)

10.4 Middle East & Africa Precision Cancer Medicine Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Detail

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Precision Cancer Medicine Introduction

11.1.4 AbbVie Revenue in Precision Cancer Medicine Business (2019-2024)

11.1.5 AbbVie Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Detail

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Precision Cancer Medicine Introduction

11.2.4 Johnson & Johnson Revenue in Precision Cancer Medicine Business (2019-2024)

11.2.5 Johnson & Johnson Recent Development

11.3 Novartis

11.3.1 Novartis Company Detail

11.3.2 Novartis Business Overview

11.3.3 Novartis Precision Cancer Medicine Introduction

11.3.4 Novartis Revenue in Precision Cancer Medicine Business (2019-2024)

11.3.5 Novartis Recent Development

11.4 Gilead Sciences

11.4.1 Gilead Sciences Company Detail

11.4.2 Gilead Sciences Business Overview

11.4.3 Gilead Sciences Precision Cancer Medicine Introduction

11.4.4 Gilead Sciences Revenue in Precision Cancer Medicine Business (2019-2024)

11.4.5 Gilead Sciences Recent Development

11.5 Roche

11.5.1 Roche Company Detail

11.5.2 Roche Business Overview

11.5.3 Roche Precision Cancer Medicine Introduction

11.5.4 Roche Revenue in Precision Cancer Medicine Business (2019-2024)

11.5.5 Roche Recent Development

11.6 Bristol-Myers Squibb

11.6.1 Bristol-Myers Squibb Company Detail

11.6.2 Bristol-Myers Squibb Business Overview

11.6.3 Bristol-Myers Squibb Precision Cancer Medicine Introduction

11.6.4 Bristol-Myers Squibb Revenue in Precision Cancer Medicine Business (2019-2024)

11.6.5 Bristol-Myers Squibb Recent Development

11.7 Amgen

11.7.1 Amgen Company Detail

11.7.2 Amgen Business Overview

11.7.3 Amgen Precision Cancer Medicine Introduction

11.7.4 Amgen Revenue in Precision Cancer Medicine Business (2019-2024)

11.7.5 Amgen Recent Development

11.8 AstraZeneca

11.8.1 AstraZeneca Company Detail

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Precision Cancer Medicine Introduction

11.8.4 AstraZeneca Revenue in Precision Cancer Medicine Business (2019-2024)

11.8.5 AstraZeneca Recent Development

11.9 Merck & Co

11.9.1 Merck & Co Company Detail

11.9.2 Merck & Co Business Overview

11.9.3 Merck & Co Precision Cancer Medicine Introduction

11.9.4 Merck & Co Revenue in Precision Cancer Medicine Business (2019-2024)

11.9.5 Merck & Co Recent Development

11.10 Takeda

11.10.1 Takeda Company Detail

11.10.2 Takeda Business Overview

11.10.3 Takeda Precision Cancer Medicine Introduction

11.10.4 Takeda Revenue in Precision Cancer Medicine Business (2019-2024)

11.10.5 Takeda Recent Development

11.11 Merck KGaA

11.11.1 Merck KGaA Company Detail

11.11.2 Merck KGaA Business Overview

11.11.3 Merck KGaA Precision Cancer Medicine Introduction

11.11.4 Merck KGaA Revenue in Precision Cancer Medicine Business (2019-2024)

11.11.5 Merck KGaA Recent Development

11.12 Seagen

11.12.1 Seagen Company Detail

11.12.2 Seagen Business Overview

11.12.3 Seagen Precision Cancer Medicine Introduction

11.12.4 Seagen Revenue in Precision Cancer Medicine Business (2019-2024)

11.12.5 Seagen Recent Development

11.13 Eli Lilly

11.13.1 Eli Lilly Company Detail

11.13.2 Eli Lilly Business Overview

11.13.3 Eli Lilly Precision Cancer Medicine Introduction

11.13.4 Eli Lilly Revenue in Precision Cancer Medicine Business (2019-2024)

11.13.5 Eli Lilly Recent Development

11.14 Ono Pharmaceutical

11.14.1 Ono Pharmaceutical Company Detail

11.14.2 Ono Pharmaceutical Business Overview

11.14.3 Ono Pharmaceutical Precision Cancer Medicine Introduction

11.14.4 Ono Pharmaceutical Revenue in Precision Cancer Medicine Business (2019-2024)

11.14.5 Ono Pharmaceutical Recent Development

11.15 Pfizer

11.15.1 Pfizer Company Detail

11.15.2 Pfizer Business Overview

11.15.3 Pfizer Precision Cancer Medicine Introduction

11.15.4 Pfizer Revenue in Precision Cancer Medicine Business (2019-2024)

11.15.5 Pfizer Recent Development

11.16 GSK

11.16.1 GSK Company Detail

11.16.2 GSK Business Overview

11.16.3 GSK Precision Cancer Medicine Introduction

11.16.4 GSK Revenue in Precision Cancer Medicine Business (2019-2024)

11.16.5 GSK Recent Development

11.17 Exelixis

11.17.1 Exelixis Company Detail

11.17.2 Exelixis Business Overview

11.17.3 Exelixis Precision Cancer Medicine Introduction

11.17.4 Exelixis Revenue in Precision Cancer Medicine Business (2019-2024)

11.17.5 Exelixis Recent Development

11.18 Regeneron

11.18.1 Regeneron Company Detail

11.18.2 Regeneron Business Overview

11.18.3 Regeneron Precision Cancer Medicine Introduction

11.18.4 Regeneron Revenue in Precision Cancer Medicine Business (2019-2024)

11.18.5 Regeneron Recent Development

11.19 Innovent

11.19.1 Innovent Company Detail

11.19.2 Innovent Business Overview

11.19.3 Innovent Precision Cancer Medicine Introduction

11.19.4 Innovent Revenue in Precision Cancer Medicine Business (2019-2024)

11.19.5 Innovent Recent Development

11.20 Hengrui Medicine

11.20.1 Hengrui Medicine Company Detail

11.20.2 Hengrui Medicine Business Overview

11.20.3 Hengrui Medicine Precision Cancer Medicine Introduction

11.20.4 Hengrui Medicine Revenue in Precision Cancer Medicine Business (2019-2024)

11.20.5 Hengrui Medicine Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Precision Cancer Medicine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Cancer Immunotherapy

Table 3. Key Players of Targeted Therapy

Table 4. Global Precision Cancer Medicine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Precision Cancer Medicine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Precision Cancer Medicine Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Precision Cancer Medicine Market Share by Region (2019-2024)

Table 8. Global Precision Cancer Medicine Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Precision Cancer Medicine Market Share by Region (2025-2030)

Table 10. Precision Cancer Medicine Market Trends

Table 11. Precision Cancer Medicine Market Drivers

Table 12. Precision Cancer Medicine Market Challenges

Table 13. Precision Cancer Medicine Market Restraints

Table 14. Global Precision Cancer Medicine Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Precision Cancer Medicine Market Share by Players (2019-2024)

Table 16. Global Top Precision Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Medicine as of 2023)

Table 17. Ranking of Global Top Precision Cancer Medicine Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Precision Cancer Medicine Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Precision Cancer Medicine Product Solution and Service

Table 21. Date of Enter into Precision Cancer Medicine Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Precision Cancer Medicine Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Precision Cancer Medicine Revenue Market Share by Type (2019-2024)

Table 25. Global Precision Cancer Medicine Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Precision Cancer Medicine Revenue Market Share by Type (2025-2030)

Table 27. Global Precision Cancer Medicine Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Precision Cancer Medicine Revenue Market Share by Application (2019-2024)

Table 29. Global Precision Cancer Medicine Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Precision Cancer Medicine Revenue Market Share by Application (2025-2030)

Table 31. North America Precision Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Precision Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Precision Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Precision Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Precision Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Precision Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Precision Cancer Medicine Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Precision Cancer Medicine Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Precision Cancer Medicine Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Precision Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Precision Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Precision Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Precision Cancer Medicine Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Precision Cancer Medicine Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Precision Cancer Medicine Market Size by Country (2025-2030) & (US$ Million)

Table 46. AbbVie Company Detail

Table 47. AbbVie Business Overview

Table 48. AbbVie Precision Cancer Medicine Product

Table 49. AbbVie Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)

Table 50. AbbVie Recent Development

Table 51. Johnson & Johnson Company Detail

Table 52. Johnson & Johnson Business Overview

Table 53. Johnson & Johnson Precision Cancer Medicine Product

Table 54. Johnson & Johnson Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)

Table 55. Johnson & Johnson Recent Development

Table 56. Novartis Company Detail

Table 57. Novartis Business Overview

Table 58. Novartis Precision Cancer Medicine Product

Table 59. Novartis Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)

Table 60. Novartis Recent Development

Table 61. Gilead Sciences Company Detail

Table 62. Gilead Sciences Business Overview

Table 63. Gilead Sciences Precision Cancer Medicine Product

Table 64. Gilead Sciences Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)

Table 65. Gilead Sciences Recent Development

Table 66. Roche Company Detail

Table 67. Roche Business Overview

Table 68. Roche Precision Cancer Medicine Product

Table 69. Roche Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)

Table 70. Roche Recent Development

Table 71. Bristol-Myers Squibb Company Detail

Table 72. Bristol-Myers Squibb Business Overview

Table 73. Bristol-Myers Squibb Precision Cancer Medicine Product

Table 74. Bristol-Myers Squibb Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)

Table 75. Bristol-Myers Squibb Recent Development

Table 76. Amgen Company Detail

Table 77. Amgen Business Overview

Table 78. Amgen Precision Cancer Medicine Product

Table 79. Amgen Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)

Table 80. Amgen Recent Development

Table 81. AstraZeneca Company Detail

Table 82. AstraZeneca Business Overview

Table 83. AstraZeneca Precision Cancer Medicine Product

Table 84. AstraZeneca Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)

Table 85. AstraZeneca Recent Development

Table 86. Merck & Co Company Detail

Table 87. Merck & Co Business Overview

Table 88. Merck & Co Precision Cancer Medicine Product

Table 89. Merck & Co Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)

Table 90. Merck & Co Recent Development

Table 91. Takeda Company Detail

Table 92. Takeda Business Overview

Table 93. Takeda Precision Cancer Medicine Product

Table 94. Takeda Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)

Table 95. Takeda Recent Development

Table 96. Merck KGaA Company Detail

Table 97. Merck KGaA Business Overview

Table 98. Merck KGaA Precision Cancer Medicine Product

Table 99. Merck KGaA Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)

Table 100. Merck KGaA Recent Development

Table 101. Seagen Company Detail

Table 102. Seagen Business Overview

Table 103. Seagen Precision Cancer Medicine Product

Table 104. Seagen Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)

Table 105. Seagen Recent Development

Table 106. Eli Lilly Company Detail

Table 107. Eli Lilly Business Overview

Table 108. Eli Lilly Precision Cancer Medicine Product

Table 109. Eli Lilly Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)

Table 110. Eli Lilly Recent Development

Table 111. Ono Pharmaceutical Company Detail

Table 112. Ono Pharmaceutical Business Overview

Table 113. Ono Pharmaceutical Precision Cancer Medicine Product

Table 114. Ono Pharmaceutical Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)

Table 115. Ono Pharmaceutical Recent Development

Table 116. Pfizer Company Detail

Table 117. Pfizer Business Overview

Table 118. Pfizer Precision Cancer Medicine Product

Table 119. Pfizer Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)

Table 120. Pfizer Recent Development

Table 121. GSK Company Detail

Table 122. GSK Business Overview

Table 123. GSK Precision Cancer Medicine Product

Table 124. GSK Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)

Table 125. GSK Recent Development

Table 126. Exelixis Company Detail

Table 127. Exelixis Business Overview

Table 128. Exelixis Precision Cancer Medicine Product

Table 129. Exelixis Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)

Table 130. Exelixis Recent Development

Table 131. Regeneron Company Detail

Table 132. Regeneron Business Overview

Table 133. Regeneron Precision Cancer Medicine Product

Table 134. Regeneron Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)

Table 135. Regeneron Recent Development

Table 136. Innovent Company Detail

Table 137. Innovent Business Overview

Table 138. Innovent Precision Cancer Medicine Product

Table 139. Innovent Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)

Table 140. Innovent Recent Development

Table 141. Hengrui Medicine Company Detail

Table 142. Hengrui Medicine Business Overview

Table 143. Hengrui Medicine Precision Cancer Medicine Product

Table 144. Hengrui Medicine Revenue in Precision Cancer Medicine Business (2019-2024) & (US$ Million)

Table 145. Hengrui Medicine Recent Development

Table 146. Research Programs/Design for This Report

Table 147. Key Data Information from Secondary Sources

Table 148. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Precision Cancer Medicine Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Precision Cancer Medicine Market Share by Type: 2023 VS 2030

Figure 3. Cancer Immunotherapy Features

Figure 4. Targeted Therapy Features

Figure 5. Global Precision Cancer Medicine Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Precision Cancer Medicine Market Share by Application: 2023 VS 2030

Figure 7. Lung Cancer Case Studies

Figure 8. Breast Cancer Case Studies

Figure 9. Prostate Cancer Case Studies

Figure 10. Blood-related Cancer Case Studies

Figure 11. Other Case Studies

Figure 12. Precision Cancer Medicine Report Years Considered

Figure 13. Global Precision Cancer Medicine Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Precision Cancer Medicine Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Precision Cancer Medicine Market Share by Region: 2023 VS 2030

Figure 16. Global Precision Cancer Medicine Market Share by Players in 2023

Figure 17. Global Top Precision Cancer Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Precision Cancer Medicine as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Precision Cancer Medicine Revenue in 2023

Figure 19. North America Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Precision Cancer Medicine Market Share by Country (2019-2030)

Figure 21. United States Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Precision Cancer Medicine Market Share by Country (2019-2030)

Figure 25. Germany Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Precision Cancer Medicine Market Share by Region (2019-2030)

Figure 33. China Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Precision Cancer Medicine Market Share by Country (2019-2030)

Figure 41. Mexico Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Precision Cancer Medicine Market Share by Country (2019-2030)

Figure 45. Turkey Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Precision Cancer Medicine Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. AbbVie Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)

Figure 48. Johnson & Johnson Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)

Figure 49. Novartis Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)

Figure 50. Gilead Sciences Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)

Figure 51. Roche Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)

Figure 52. Bristol-Myers Squibb Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)

Figure 53. Amgen Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)

Figure 54. AstraZeneca Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)

Figure 55. Merck & Co Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)

Figure 56. Takeda Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)

Figure 57. Merck KGaA Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)

Figure 58. Seagen Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)

Figure 59. Eli Lilly Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)

Figure 60. Ono Pharmaceutical Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)

Figure 61. Pfizer Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)

Figure 62. GSK Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)

Figure 63. Exelixis Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)

Figure 64. Regeneron Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)

Figure 65. Innovent Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)

Figure 66. Hengrui Medicine Revenue Growth Rate in Precision Cancer Medicine Business (2019-2024)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Precision Cancer Imaging System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-23Z10214

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Cryosurgical Equipment for Cancer Treatment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-39B12765

Thu Feb 20 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Brachytherapy Accessories Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24Q18678

Tue Feb 18 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Gynecological Cancer Diagnostics Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30P10282

Mon Feb 17 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Precision Cancer Medicine Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-35A15351

Global Precision Cancer Medicine Market Research Report 2024

FEATURED COMPANIES

Precision Cancer Medicine Market Size

Precision Cancer Medicine Market

Report Scope

Scope of Precision Cancer Medicine Market Report

Chapter Outline

FAQ for this report

How fast is Precision Cancer Medicine Market growing?

What is the Precision Cancer Medicine Market size in 2030?

Who are the main players in the Precision Cancer Medicine Market report?

What are the Application segmentation covered in the Precision Cancer Medicine Market report?

What are the Type segmentation covered in the Precision Cancer Medicine Market report?

FEATURED COMPANIES

RELATED REPORTS

$5800

Enterprise User

$5800

Enterprise User

$5800

Enterprise User

$5800

Enterprise User